- Home
- VRCA vs RBOT Comparison
VRCA vs RBOT Comparison
Compare VRCA & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRCA | RBOT |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 17.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | VRCA | RBOT |
|---|---|---|
| Price | $8.19 | $3.15 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 358.1K | 133.8K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,829,000.00 | N/A |
| Revenue This Year | $332.45 | N/A |
| Revenue Next Year | $12.85 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 234.73 | N/A |
| 52 Week Low | $3.28 | $2.44 |
| 52 Week High | $13.00 | $19.00 |
Technical Indicators
Market Signals| Indicator | VRCA | RBOT |
|---|---|---|
| Relative Strength Index (RSI) | 69.86 | 41.39 |
| Support Level | $6.26 | $2.54 |
| Resistance Level | $9.82 | $3.66 |
| Average True Range (ATR) | 0.90 | 0.39 |
| MACD | 0.41 | 0.11 |
| Stochastic Oscillator | 75.38 | 52.34 |
Price Performance
Historical ComparisonAbout VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.